TP53 and Familial prostate cancer: (2) Methods: We combined wet-lab experiments (MTT viability assay and ELISA measurements of total NF-κB p65 and p53) with a Bayesian digital twin framework to quantify signalling dynamics in prostate cancer cells following CAPE exposure.